Xponance’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $557K | Sell |
10,487
-14,485
| -58% | -$770K | ﹤0.01% | 910 |
|
2025
Q1 | $1.08M | Buy |
24,972
+959
| +4% | +$41.5K | 0.01% | 665 |
|
2024
Q4 | $1.35M | Buy |
24,013
+2,264
| +10% | +$127K | 0.01% | 622 |
|
2024
Q3 | $1.48M | Buy |
21,749
+173
| +0.8% | +$11.8K | 0.01% | 595 |
|
2024
Q2 | $912K | Buy |
21,576
+799
| +4% | +$33.8K | 0.01% | 700 |
|
2024
Q1 | $1.43M | Buy |
20,777
+8,372
| +67% | +$578K | 0.02% | 618 |
|
2023
Q4 | $918K | Sell |
12,405
-668
| -5% | -$49.4K | 0.01% | 701 |
|
2023
Q3 | $892K | Buy |
13,073
+235
| +2% | +$16K | 0.01% | 682 |
|
2023
Q2 | $1.21M | Buy |
12,838
+3,303
| +35% | +$310K | 0.02% | 604 |
|
2023
Q1 | $647K | Buy |
9,535
+33
| +0.3% | +$2.24K | 0.01% | 822 |
|
2022
Q4 | $470K | Buy |
9,502
+2,740
| +41% | +$136K | 0.01% | 916 |
|
2022
Q3 | $220K | Buy |
6,762
+177
| +3% | +$5.76K | ﹤0.01% | 1070 |
|
2022
Q2 | $259K | Sell |
6,585
-11,927
| -64% | -$469K | 0.01% | 1045 |
|
2022
Q1 | $1.29M | Buy |
18,512
+339
| +2% | +$23.7K | 0.02% | 508 |
|
2021
Q4 | $1.41M | Buy |
18,173
+6
| +0% | +$467 | 0.02% | 488 |
|
2021
Q3 | $1.73M | Sell |
18,167
-425
| -2% | -$40.6K | 0.03% | 377 |
|
2021
Q2 | $2.31M | Buy |
18,592
+5,110
| +38% | +$635K | 0.04% | 333 |
|
2021
Q1 | $1.78M | Buy |
13,482
+150
| +1% | +$19.8K | 0.04% | 341 |
|
2020
Q4 | $1.77M | Sell |
13,332
-163
| -1% | -$21.6K | 0.04% | 334 |
|
2020
Q3 | $1.38M | Buy |
13,495
+57
| +0.4% | +$5.81K | 0.03% | 351 |
|
2020
Q2 | $1.17M | Buy |
+13,438
| New | +$1.17M | 0.03% | 355 |
|